A Conserved Domain of HCV E2 Glycoprotein Interacts with Human CD81 and Induces Interferon-Gamma Secretion from Peripheral Blood Mononuclear Cells
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2810239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Zhiyan Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chon…. Hauptthemen laut MEDLINE: Hepatitis C, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatitis C virus (HCV) infection is a global health threat to the public, and vaccines against it are not yet available. The HCV envelope glycoprotein E2 is a key target for anti-HCV vaccines. The majority of previous studies have focused on the hypervariable region and the glycosylation sites of the_HCV structural protein. This study aims to investigate a conserved domain of HCV E2 glycoprotein and explore its potential to induce an immune response against HCV.
Methods
HCV E2 conserved domain (encompassing amino acids 505–702) was prepared in Escherichia coli (E. coli). Peripheral blood mononuclear cells (PBMCs) were isolated from patients with HCV or healthy controls. Interferon-gamma (IFN-γ) enzyme-linked immunosorbent spot assay was conducted to examine the HCV E2-specific immune response as reflected by IFN-γ-secreting cells/106 PBMCs.
Results
HCV E2 conserved domain was highly conserved among 25 HCV subtypes, and its recombinant soluble production in E. coli was recognized by anti-HCV E2 monoclonal antibodies. This study characterized in vitro direct interaction between bacterially expressed HCV E2 conserved domain and human CD81 (hCD81). Furthermore, the recombinant HCV E2_conserved domain markedly induced the production of IFN-γ by PBMCs from patients with HCV. Its stimulated specific immune response was significantly different from non-specific peptide controls or PBMCs isolated from healthy controls.
Conclusions
HCV E2 conserved domain directly binds hCD81 and activates the production of IFN-γ in the PBMCs of patients with HCV. Therefore, the conserved domain of HCV E2 glycoprotein may be a new candidate for developing an HCV vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chongqing Medical University, 610031 Chengdu, Sichuan, China.
- Department of Critical Care Medicine, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chongqing Medical University, 610031 Chengdu, Sichuan, China.
- Department of Infectious diseases, The Third Affiliated Hospital of Sun Yat-sen university, 510630 Guangzhou, Guangdong, China.
Zitieren
APA
Dai, Z., Zeng, W., Li, G., & Shu, X. (2023). A Conserved Domain of HCV E2 Glycoprotein Interacts with Human CD81 and Induces Interferon-Gamma Secretion from Peripheral Blood Mononuclear Cells. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2810239
Vancouver
Dai Z, Zeng W, Li G, Shu X. A Conserved Domain of HCV E2 Glycoprotein Interacts with Human CD81 and Induces Interferon-Gamma Secretion from Peripheral Blood Mononuclear Cells. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2810239
BibTeX
@article{Dai2023,
author = {Dai, Zhiyan and Zeng, Wei and Li, Gang and Shu, Xin},
title = {A Conserved Domain of HCV E2 Glycoprotein Interacts with Human CD81 and Induces Interferon-Gamma Secretion from Peripheral Blood Mononuclear Cells},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2810239}
}
EUVIMED